Reminders for booster jab and repeat vaccination against COVID-19 Adults who have not yet had a booster jab or repeat vaccination against COVID-19 will receive a reminder letter from RIVM, starting Friday 8 July 2022.
SARS-CoV-2 infections rising less rapidly 39,283 positive COVID-19 tests were reported in the Netherlands last week*. That is an increase of 15% compared to the week before that. This means that the number of reported infections is still rising, but not as rapidly as in the previous weeks.
Operations postponed due to pandemic result in 320,000 healthy life years lost The COVID-19 pandemic caused over 305,000 operations to be postponed in 2020 and 2021 in the Netherlands.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
Pressure drainage can be a cost-effective technology to reduce CO2 emissions in peatland areas Pressure drainage can in some cases help to reduce CO2 emissions in peatland areas. This intervention is very expensive and only cost-effective when it sufficiently reduces CO2 emissions.
Patient in Radboudumc not contaminated with the Ebola virus The patient, who was admitted in the Radboud univerisity medical center over the past few days because of a suspected Ebola infection, was proven not to be infected.
Outbreak of avian influenza A (H5N8) in Dutch poultry In November 2014 avian ‘flu has been detected on poultry farms in the Netherlands.
Promising biobased alternatives to substances of very high concern There are many possible biobased alternatives to substances of very high concern (SVHC). Some are even ready to be deployed right away.
European Antibiotic Awareness Day 2014 Tuesday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe, attention is focused on the responsible use of antibiotics for people and animals.
Partnering as effective strategy to bring new drugs to European market Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f